Member Exclusive

CRISPR used to develop cell therapies for cystic fibrosis

Using CRISPR/Cas9, researchers have developed autologous gene-corrected primary Krt5+ airway basal stem cells as a cell therapy for cystic fibrosis.

Go to the profile of RegMedNet
Apr 29, 2019

Please sign in or register for FREE

No comments yet.